FrancophonIA/ELRC3.0 huggingface dataset:
English: Tasermity contains sevelamer, a non-absorbed phosphate binding poly (allylamine hydrochloride) polymer, free of metal and calcium.
Estonian: Tasermity'i tabletid sisaldavad sevelameeri, mitteabsorbeeruvat fosfaatisiduvat ainet polü(allülamiinhüdrokloriid)polümeeri, mis ei sisalda metalli ega kaltsiumi.
English: Genzyme Europe B.V. Gooimeer 10
Estonian: Genzyme Europe B.V.
English: In a study in rats, administering sevelamer in 15-30 x the human dose, an increase in serum copper was detected.
Estonian: Loomkatses rottidega, kellele manustati sevelameeri inimannusest 15...30 korda rohkem, täheldati vasesisalduse suurenemist seerumis.
English: Sevelamer hydrochloride has no or negligible influence on the ability to drive and use machines.
Estonian: Sevelameervesinikkloriidil ei ole toimet või on ebaoluline toime autojuhtimisele ja masinate käsitsemise võimele.
English: In parallel design studies involving 244 haemodialysis patients with treatment duration of up to 54 weeks and 97 peritoneal dialysis patients with treatment duration of 12 weeks were conducted Adverse reactions from these studies (299 patients), from uncontrolled clinical trials (384 patients) and that were spontaneously reported from post-marketing experience are listed by frequency in the table below.
Estonian: Neist uuringutest (299 patsienti), kontrollgrupita kliinilistest uuringutest (384 patsienti) ja turustamisjärgsetest kõrvaltoimeteatistest pärinevad kõrvaltoimed on esinemissageduse järgi loetletud alljärgnevas tabelis.
English: Acidosis, increased chloride
Estonian: Atsidoos, kloriidisisalduse suurenemine vereseerumis
English: Closer monitoring of patients with hypothyroidism co-administered with sevelamer hydrochloride and levothyroxine is recommended (see section 4.5).
Estonian: Hüpotüreoosiga patsiente, kellele manustatakse samaaegselt sevelameervesinikkloriidi ja levotüroksiini, on soovitatav hoolikalt jälgida (vt lõik 4.5).
English: In animal studies there was no evidence that sevelamer induced embryo-foetal toxicity.
Estonian: Loomkatsete põhjal puuduvad andmed, et sevelameer on embrüo- ja lootetoksiline.
English: Tasermity may be used with other medicines which include calcium or vitamin D supplements to control the development of renal bone disease.
Estonian: Tasermity't tohib kasutada koos teiste ravimitega, sealhulgas kaltsiumi ja D-vitamiini ravimpreparaatidega, neerudest tingitud luuhaiguse raviks.
English: Sevelamer hydrochloride does not contain calcium.
Estonian: Sevelameervesinikkloriid ei sisalda kaltsiumit.
English: • if you have prolonged diarrhoea or pain in the abdomen (symptoms of active inflammatory bowel disease)
Estonian: • kui teil on pikka aega kõht lahti või kõht valutab (ägeda, põletikulise soolehaiguse sümptomid), • kui teil on olnud mao- või seedetrakti suuremahuline operatsioon.
English: In very rare cases, intestinal obstruction and ileus/subileus have been observed in patients during treatment with sevelamer hydrochloride.
Estonian: Väga harvadel juhtudel on patsientidel täheldatud sooleobstruktsiooni ja iileust/subiileust ravi ajal sevelameervesinikkloriidiga.
English: Adult patients whose kidneys have failed and who are undergoing haemodialysis or peritoneal dialysis are not able to control the level of serum phosphate in their blood.
Estonian: Hemodialüüsi või peritoneaaldialüüsi saavad neerupuudulikkusega patsiendid ei suuda kontrollida seerumi fosfaaditaset oma veres.
English: How to take Tasermity
Estonian: Kuidas Tasermity't võtta
English: Sevelamer hydrochloride alone is not indicated for the control of hyperparathyroidism.
Estonian: Sevelameervesinikkloriid ainuravimina ei ole näidustatud hüperparatüreoosi kontrolli all hoidmiseks.
English: The effects may be secondary to vitamin D and/or vitamin K depletion at these high doses.
Estonian: Sekundaarne mõju nii suurte annuste puhul võib olla D ja/või K vitamiinipuuduse tekkimine organismis.
English: The tablets are packed in high density polyethylene bottles with a child resistant polypropylene closure and an induction seal.
Estonian: Tabletid on pakendatud kõrgtihedast polüetüleenist pudelitesse, millel on lapsekindel polüpropüleenist sulgur ja fooliumist kaitsekile.
English: • The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used in transplant patients) may be reduced by Tasermity.
Estonian: • Tasermity võib vähendada ravimite, näiteks tsüklosporiini, mükofenolaatmofetiili ja takroliimuse (siirdatud elundiga patsientidel kasutatavad ravimid) toimet.
English: - The other ingredients are silica colloidal anhydrous and stearic acid, hypromellose (E464), diacetylated monoglycerides, iron oxide black (E172) and propylene glycol.
Estonian: − Teised koostisosad on veevaba kolloidne ränidioksiid ja steariinhape, hüpromelloos (E464),
English: Package leaflet: Information for the user Tasermity 800 mg film-coated tablets sevelamer hydrochloride
Estonian: Pakendi infoleht: teave kasutajale Tasermity 800 mg õhukese polümeerikattega tabletid sevelameervesinikkloriid (sevelameri hydrochloridum)
English: Do not store above 25ºC.
Estonian: Hoida temperatuuril kuni 25ºC.
English: In clinical trials, sevelamer hydrochloride has been shown to be effective in reducing serum phosphorus in patients receiving haemodialysis or peritoneal dialysis.
Estonian: Kliinilistes uuringutes on näidatud, et sevelameervesinikkloriid vähendab tõhusalt seerumi fosfaadisisaldust hemodialüüsi või peritoneaaldialüüsi saavatel patsientidel.
English: Patients should take sevelamer hydrochloride with meals and adhere to their prescribed diets.
Estonian: Sevelameervesinikkloriidi tuleb manustada koos toiduga ning patsiendid peavad järgima ettekirjutatud dieeti.
English: What Tasermity is and what it is used for
Estonian: Mis ravim on Tasermity ja milleks seda kasutatakse
English: The safety of sevelamer hydrochloride has not been established in pregnant women.
Estonian: Sevelameervesinikkloriidi ohutus rasedatel ei ole kindlaks tehtud.
English: During post-marketing experience, very rare cases of increased phosphate levels have been reported in patients taking proton pump inhibitors co-administered with sevelamer hydrochloride.
Estonian: Turuletulekujärgselt on väga harva teatatud fosfaaditaseme tõusust patsientidel, kes saavad samaaegset ravi prootonpumba inhibiitorite ja sevelameervesinikkloriidiga.
English: Therefore, your doctor may monitor the levels of vitamin D in your blood and prescribe additional vitamin D as necessary.
Estonian: Pärast D-vitamiin taseme kontrollimist veres võib arst teile vajaduse korral välja kirjutada D-vitamiin preparaate.
English: Patients who are constipated should be monitored carefully while being treated with sevelamer hydrochloride.
Estonian: Kõhukinnisusega patsiente tuleb ravi ajal sevelameervesinikkloriidiga tähelepanelikult jälgida.
English: In a clinical trial of one-year duration, sevelamer hydrochloride had no adverse effect on bone turnover or mineralisation compared to calcium carbonate.
Estonian: Üheaastases kliinilises uuringus ei täheldatud sevelameervesinikkloriidil kõrvaltoimeid, mis põhjustaksid suuremaid muutusi luudes või mineralisatsiooni kui kaltsiumkarbonaat.
English: Film-coated tablet (tablet) The off-white, oval tablets are imprinted with “SH800” on one side.
Estonian: Valkjad ovaalsed tabletid, mille ühel poolel on märgistus „SH800".
English: Tasermity is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.
Estonian: Tasermity on näidustatud hüperfosfateemia kontrolliks täiskasvanud patsientidel, kes saavad hemodialüüsi või peritoneaaldialüüsi.
English: By binding phosphate in the gastrointestinal tract, sevelamer lowers the phosphate concentration in the serum.
Estonian: Sidudes fosfaati seedetraktis, langetab sevelameer fosfaadi kontsentratsiooni seerumis.
English: Therefore caution should be exercised when sevelamer hydrochloride is used in patients with these disorders.
Estonian: Seetõttu tuleb nimetatud haigustega patsientide puhul sevelameervesinikkloriidi kasutada ettevaatusega.
English: 4.2 Posology and method of administration
Estonian: 4.2 Annustamine ja annustamisviis
English: Caution should be exercised when prescribing sevelamer hydrochloride to patients also taking these medicinal products.
Estonian: Sevelameervesinikkloriidi määramisel patsientidel, kes võtavad ka neid ravimeid, tuleb olla ettevaatlik.
English: There is at present insufficient data to exclude the possibility of folate deficiency during long term sevelamer hydrochloride treatment.
Estonian: Andmete ebapiisavuse tõttu ei saa pikaajalisel ravil sevelameervesinikkloriidiga välistada folaadipuuduse teket.
English: Patients with chronic renal failure are predisposed to developing metabolic acidosis.
Estonian: Neerupuudulikkusega patsientidel on eelsoodumus metaboolse atsidoosi tekkeks.
English: HDPE bottles, with a child resistant polypropylene closure and a foil induction seal.
Estonian: HDPE-pudelid lastekindla polüpropüleensulguri ja fooliumist kaitsekilega.
English: • if you are not on dialysis
Estonian: • kui te ei saa dialüüsravi,
English: Each tablet contains 800 mg sevelamer hydrochloride.
Estonian: Üks tablett sisaldab 800 mg sevelameervesinikkloriidi.
English: - The active substance is sevelamer hydrochloride.
Estonian: − Toimeaine on sevelameervesinikkloriid.
English: You should tell your doctor immediately if you experience any new signs or symptoms of abdominal distress, abdominal swelling, abdominal pain, abdominal tenderness, or abdominal rigidity, constipation, fever, chills, nausea or vomiting.
Estonian: Kui teil ilmnevad sellised uued sümptomid nagu pingetunne kõhus, kõhu esilevõlvumine, kõhuvalu, hellus kõhupiirkonnas, kõhu jäikus, kõhukinnisus, palavik, külmavärinad, iiveldus või oksendamine, peate sellest otsekohe teatama oma arstile.
English: During post marketing experience, very rare cases of increased thyroid stimulating hormone (TSH) levels have been reported in patients co-administered sevelamer hydrochloride and levothyroxine.
Estonian: Turustusjärgselt on väga harva teatatud türeotropiini (TSH) kõrgenenud taseme juhtudest sevelameervesinikkloriidi ja levotüroksiini koosmanustamisel patsientidele.
English: In patients with secondary hyperparathyroidism sevelamer hydrochloride should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25-dihydroxy Vitamin D3 or one of its analogues to lower the iPTH levels.
Estonian: Sekundaarse hüperparatüreoosiga patsiendid peavad Tasermity'i kasutama kompleksse ravi kontekstis, mis sisaldab kaltsiumilisandeid, 1,25dihüdroksüvitamiini D3 või ühte selle analoogidest, et langetada iPTH taset.
English: The safety of Tasermity has not been established in pregnant or breast-feeding women.
Estonian: Tasermity ohutust rasedatel või imetavatele naistel ei ole kindlaks tehtud.
English: Tasermity 800 mg film-coated tablets sevelamer hydrochloride
Estonian: Tasermity 800 mg õhukese polümeerikattega tabletid sevelameri hydrochloridum
English: In patients with secondary hyperparathyroidism sevelamer hydrochloride should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25-dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels.
Estonian: Sekundaarse hüperparatüreoosiga patsiendid peaksid sevelameervesinikkloriidi kasutama kompleksse ravi kontekstis, mis sisaldab kaltsiumilisandeid, 1,25-dihüdroksüvitamiin D3 või ühte selle analoogidest, et langetada kahjustamata intaktse parathormooni (iPTH) taset.
English: How to store Tasermity
Estonian: Kuidas Tasermity't säilitada
English: Sevelamer hydrochloride should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.
Estonian: Sevelameervesinikkloriidi tuleks kasutada kompleksse ravi kontekstis, mis võiks sisaldada kaltsiumilisandeid, 1,25-dihüdroksüvitamiini D3 või ühte selle analoogidest, et kontrollida renaalse luuhaiguse teket.
English: Uncommon reports of difficulty swallowing the sevelamer hydrochloride tablet have been reported.
Estonian: Aeg-ajalt on teatatud raskustest sevelameervesinikkloriidi tablettide neelamisel.
English: Tasermity is used to control the levels of phosphate in the blood of adult kidney failure patients on haemodialysis or peritoneal dialysis treatment.
Estonian: Tasermity't kasutatakse fosfaaditaseme ohjamiseks neerupuudulikkusega täiskasvanud patsientidel, kes saavad hemodialüüsi või peritoneaaldialüüsi.
English: Film-coating:
Estonian: Kattekile:
English: Sevelamer has been shown to bind bile acids in vitro and in vivo in experimental animal models.
Estonian: Eksperimentaalsed loomkatsed näitasid, et sevelameer seob sapphapet in vitro ja in vivo.
English: The safety of sevelamer hydrochloride has not been established in breast-feeding women.
Estonian: Sevelameervesinikkloriidi ohutus kohta imetavatele naistel ei ole kindlaks tehtud.
English: Worsening of acidosis has been reported upon switching from other phosphate binders to sevelamer in a number of studies where lower bicarbonate levels in the sevelamer-treated patients compared to patients treated with calcium-based binders were observed.
Estonian: Mitmetes uuringutes, kus sevelameeriga ravitud patsientidel esinesid madalamad bikarbonaadi väärtused kaltsiumil põhinevate sidujate kasutamisega võrreldes, tuvastati atsidoosi süvenemine pärast teist tüüpi fosfaadi sidujate asendamist sevelameeriga.
English: Tasermity 800 mg film-coated tablets
Estonian: Tasermity 800 mg õhukese polümeerikattega tabletid
English: Hypothyroidism
Estonian: Hüperparatüreoos
English: Zentiva Pharma GmbH Tel: +49 (0) 180 20 200 10
Estonian: Sanofi-Aventis Deutschland GmbH Tel: +49 (0)180 2 222010
English: He/she will base the dose on your serum phosphate level.
Estonian: Ta määrab annuse vastavalt fosfaaditasemele teie veres.
English: Anti-arrhythmics and anti-seizure medicinal products Patients taking anti-arrhythmic medicinal products for the control of arrhythmias and anti-seizure medicinal products for the control of seizure disorders were excluded from clinical trials.
Estonian: Kliinilistesse uuringutesse ei kaasatud patsiente, kes võtsid antiarütmikume arütmia ohjamiseks ja krambivastaseid ravimeid krambihoogude vastu.
English: Deficits in skeletal ossification were observed in several locations in fetuses of female rats dosed with sevelamer at 8-20 times the maximum human dose of 200 mg/kg.
Estonian: Sevelameeri annuste puhul, mis ületasid 8...20 korda maksimaalse inimannuse (200 mg/kg), täheldati emasroti loodetel skeleti osalist ebapiisavat luustumist.
English: Special note for patients on peritoneal dialysis:
Estonian: Eriteade peritoneaaldialüüsi patsientidele
English: What Tasermity is and what it is used for 2.
Estonian: Mis ravim on Tasermity ja milleks seda kasutatakse.
English: Starting dose of Sevelamer hydrochloride 800 mg tablets
Estonian: Sevelameervesinikkloriidi alustusannus 800 mg tablettidena
English: Elemental calcium should be given as a supplement in case of hypocalcaemia.
Estonian: Hüpokaltseemia puhul tuleb patsientidele manustada täiendavalt kaltsiumit.
English: The following side effects have been reported in patients taking Tasermity: Very common (may affect more than 1 in 10 people): nausea, vomiting
Estonian: Väga sage (võib esineda rohkem kui 1 inimesel 10 kohta): iiveldus, oksendamine.
English: Caution should be exercised when sevelamer hydrochloride is used in patients with difficulty swallowing.
Estonian: Sevelameervesinikkloriidi kasutamisel neelamisraskustega patsientidel tuleb olla ettevaatlik.
English: This risk can be reduced by careful adherence to sterile techniques during bag changes.
Estonian: Teil võib tekkida peritoneaaldialüüsiga seotud kõhukelmepõletik (kõhuõõnes oleva vedeliku nakkus), kuid selle haiguse tekkeriski võib vähendada, kui dialüüsikottide vahetamisel hoolikalt järgida steriilset tehnikat.
English: 2 times the maximum clinical trial dose of 13 g/day, based on a comparison of relative body surface area.
Estonian: Loomkatsed on näidanud, et sevelameer ei kahjusta isaste ega emaste rottide fertiilsust süsteemse saadavuse korral, mis inimesel vastab 2 korda suuremale annusele kui maksimaalne annus kliinilistes uuringutes - 13 g/päevas, kehapindala suhtelise võrdluse alusel.
English: Uncommon (may affect up to 1 in 100 people): increased acidity of the blood.
Estonian: Aeg-ajalt (võib esineda kuni 1 inimesel 100-st):
English: Contents of the pack and other information
Estonian: Kuidas Tasermity't säilitada Pakendi sisu ja muu teave
English: Sevelamer hydrochloride treatment should be re-evaluated in patients who develop severe gastrointestinal symptoms.
Estonian: Patsientidel, kellel tekivad rasked gastrointestinaalsümptomid, tuleb ravi sevelameervesinikkloriidiga (-karbonaadiga) uuesti hinnata.
English: Since Tasermity does not contain calcium your doctor might prescribe additional calcium tablets.
Estonian: • teil kujuneb madal või kõrge kaltsiumitase veres; Tasermity ei sisalda kaltsiumi, mistõttu võib arst teile lisaks välja kirjutada kaltsiumitablette;
English: Serum phosphate level in patients not on
Estonian: Seerumi fosfaaditase patsientidel, kes ei saa fosfaati siduvaid aineid
English: Inflammatory Gastrointestinal Disorders
Estonian: Põletikulised seedetrakti häired
English: Sevelamer hydrochloride treatment should be re-evaluated in patients who develop severe constipation or other severe gastrointestinal symptoms.
Estonian: Raske kõhukinnisuse või muude raskete gastrointestinaalsete sümptomite tekkel tuleb uuesti hinnata vajadust raviks sevelameervesinikkloriidiga.
English: Silica, colloidal anhydrous Stearic acid
Estonian: Tableti sisu: Veevaba kolloidne ränidioksiid
English: Uncommon Very Rare
Estonian: Väga sage Sage
English: Nederland sanofi-aventis Netherlands B.V. Tel: +31 182 557 755
Estonian: Κύπρος sanofi-aventisˇCyprus Ltd. Τηλ: +357 22 871600
English: 49 x 1 tablets (unit dose)
Estonian: 196 (2X 98) tabletti
English: Tradename Strength Pharmaceutical Form
Estonian: EL number Nimetus Tugevus Ravimvorm Loomaliigid Manustamisviis Pakend
English: Package size
Estonian: Pakendi suurus Keeluajad
English: What is Cerepro?
Estonian: Mis on Cerepro?
English: If you are in a clinical trial and need more information about your treatment, contact the doctor who is giving it to you.
Estonian: Kui osalete kliinilises uuringus ja vajate rohkem teavet oma ravi kohta, võtke ühendust arstiga, kes teile selle määras.
English: The main measure of effectiveness was how long the patients survived after the first operation.
Estonian: Peamine tõhususe näitaja oli patsientide elulemus pärast esimest operatsiooni.
English: The Committee also had concerns over the ways in which the study had been carried out, which made it difficult to interpret the results.
Estonian: Komitee arvas ka, et kõnealuse uuringu tegemise viis muudab tulemuste tõlgendamise raskeks.
English: The letter from the company notifying the EMEA of the withdrawal of the application is available here.
Estonian: Ettevõtte kiri, milles teatatakse EMEAle taotluse tagasivõtmisest, on kättesaadav siin.
English: Cerepro would only have worked in combination with ganciclovir.
Estonian: Cerepro oleks toiminud ainult koos gantsükloviiriga.
English: Cerepro was designated an orphan medicinal product on 6 February 2002.
Estonian: Cereprole oli antud harva kasutatava ravimi nimetus 6. veebruaril 2002.
English: After removing as much of the brain tumour as possible, the surgeon would have made up to 70 small injections of Cerepro into the area from where the tumour was removed.
Estonian: Pärast ajukasvaja eemaldamist nii suures osas kui võimalik oleks kirurg teinud kasvaja eemaldamiskohta kuni 70 väikest Cerepro süsti.
English: Glioma is a type of brain tumour that begins in ‘glial' cells (the cells that surround and support nerve cells).
Estonian: Glioom on ajukasvaja liik, mis saab alguse gliiarakkudest (närvirakke ümbritsevad ja toetavad rakud).
English: Cerepro was intended for use during an operation.
Estonian: Cereprod kavatseti kasutada operatsiooni ajal.
English: The evaluation had finished and the CHMP had given a negative opinion.
Estonian: Hindamine oli lõppenud ja inimtervishoius kasutatavate ravimite komitee oli andnud negatiivse arvamuse.
English: This enzyme helps to convert ganciclovir into a form which can kill cells that are dividing, including any cancerous cells that were not removed during the operation.
Estonian: See ensüüm aitab muundada gantsükloviiri ühendiks, mis suudab hävitada jagunevaid rakke, sealhulgas ka neid kasvajarakke, mida operatsiooni ajal ei eemaldatud.
English: Cerepro injection was to be followed by a two-week course of treatment with ganciclovir sodium, starting five days after the operation.
Estonian: Cerepro süstidele oleks järgnenud kahenädalane ravikuur naatriumgantsükloviiriga, mis oleks alanud viis päeva pärast operatsiooni.
English: The gene is carried within a ‘vector', a type of virus that has been altered genetically so that it can carry a gene (DNA) into the cells of the body.
Estonian: Geeni kannab vektor - teatud liiki viirus, mida on geneetiliselt muudetud nii, et see saaks viia geeni (DNA) keharakkudesse.
English: Ref. EMA/318692/2007
Estonian: London, 19. juuli 2007 Viitedokument: EMA/382253/2007
English: It was concerned over the low number of patients included in the main study of Cerepro, which prevented a benefit of the medicine being demonstrated.
Estonian: Komitee arvas, et Cerepro peamisesse uuringusse oli kaasatud liiga vähe patsiente ja see ei võimaldanud näidata ravimi kasulikkust.
English: The virus in Cerepro is an ‘adenovirus' that has been engineered so that it cannot make copies of itself and therefore does not cause infections in humans.
Estonian: Cerepros olev viirus on adenoviirus, mida on muudetud selliselt, et see ei suuda iseseisvalt paljuneda ega põhjusta seetõttu inimestel nakkust.
English: On 13 July 2007, Ark Therapeutics officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Cerepro, for the treatment of patients with operable high-grade glioma.
Estonian: 13. juulil 2007. aastal teatas Ark Therapeutics ametlikult inimtervishoius kasutatavate ravimite komiteele oma otsusest võtta tagasi ravimi Cerepro müügiloa taotlus.
English: What are the consequences of the withdrawal for patients in clinical trials with Cerepro?
Estonian: Millised on taotluse tagasivõtmise tagajärjed praegu Cerepro kliinilistes uuringutes osalevatele patsientidele?
English: Cerepro has also been studied in 36 patients with high-grade glioma.
Estonian: Cereprot on uuritud ka 36-l raskekujulise glioomiga patsiendil.
English: In addition, the CHMP considered there to be insufficient information on the safety of Cerepro, and, since the benefits of the medicine had not been demonstrated, that its risks, when used in combination with ganciclovir, could be of concern.
Estonian: Lisaks sellele otsustas inimtervishoius kasutatavate ravimite komitee, et Cerepro ohutuse kohta ei ole piisavalt andmeid, ning arvestades seda, et ravimi kasulikkust ei ole veel tõendatud, võivad ravimi ja gantsükloviiri kooskasutamise ohud tekitada probleeme.
English: The company informed the CHMP that there are no consequences for patients currently included in clinical trials with Cerepro.
Estonian: Ettevõte teavitas inimtervishoius kasutatavate ravimite komiteed, et tagajärjed Cerepro kliinilistesse uuringutesse hetkel kaasatud patsientidele puuduvad.
English: The study compared the effects of adding Cerepro and ganciclovir sodium to standard treatment with the effects of standard treatment alone.
Estonian: Uuringus võrreldi Cerepro ja naatriumgantsükloviiri tavapärasele ravile lisamise toimet ainult tavapärase ravi toimega.